Zosano Pharma Corp (NASDAQ: ZSAN) stock is up 35% pre-market. Recently CSols Inc. was contracted to verify WinLims for Zosano.
Market Action:
On Friday, ZSAN stock fell 1.32% at $0.6049 with more than 2.96 million shares, compared to its average volume of 982.23K shares. The stock has moved within a range of $0.5950 – 0.6128 after opening the trade at $0.6110.
CSols Inc. Validates New LIMS at Zosano Pharma
Zosano is planning to move from paper record-keeping to leverage enhanced data efficiency and accessibility of lab information management systems. The validation of LIMS for its due application is a best practice in the pharmaceutical sector that requires unique skills sets and considerable time. Zosano sought the CSols’ services to guarantee that the WinLIMS validation was successful, exceeding regulatory conditions and sector best practices.
Michael Pacheco, Zosano’s IT Director, said that the implementation of WinLIMS is an essential milestone for the company in its automation process and streamlining data collection. Notably, validation is an important aspect that is among the GxP requirements. Pacheco added that in an effort to complement the necessary resources for the validation, the company collaborated with CSols because of their understanding and knowledge of lab operations. Therefore, in the coming weeks, ZSAN is worth watching.
Technical Data
ZSAN stock is trading below the 20-Day and 50-Day Moving averages of $0.63 and $0.67 respectively. Moreover, the stock is trading below 200-Day moving average of $0.92. The stock is up 15% so far this year.
